Published in Physician Business Week, March 16th, 2004
TPO "plays a pivotal role in megakaryopoiesis," and "initiates its biological effects by binding to its receptor Mp1," scientists in Seattle explained.
In a study conducted by V.C. Broudy and coauthors at Harborview Medical Center, a "recombinant protein consisting of a carrier Fc domain linked to multiple Mpl-binding domains was constructed" and named AMG531.
"To define the biological activity of AMG531," the collaborators "examined the ability of AMG531 to support CFU-Meg growth and to promote megakaryocyte maturation in vitro."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.